Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 55 or older.
- People who are able to manage their own daily activities independently and who score 26 or higher on a standard memory and thinking test.
- Women who have been through menopause (this applies because hormonal changes can affect sleep and the body's internal systems being studied).
- People who spend no more than 8.5 hours in bed each night.
- People who are not regularly active — meaning they do less than 30 minutes of moderate exercise per day, and exercise fewer than two days per week on a regular basis.
- People whose daily light exposure is typical of someone who spends most of their time indoors (assessed by questionnaire).
For the insomnia group specifically, people who also meet these criteria may be considered:
- People whose sleep problems meet the definition of chronic insomnia disorder under an international sleep classification system.
- People who report sleeping less than 85% of the time they spend in bed, or who regularly wake earlier than wanted (before 6am) on at least 3 nights per week over the past 4 weeks.
- People who report spending 60 minutes or more awake during the night on at least 3 nights per week over the past 4 weeks (this includes time awake after first falling asleep, as well as time lying awake after waking for the final time).
- People who score above 5 on a standard sleep quality questionnaire called the PSQI.
For the healthy sleep (control) group specifically, people who also meet these criteria may be considered:
- People with no history of any type of insomnia disorder.
- People who report sleeping more than 85% of the time they spend in bed.
- People who report sleeping an average of between 6.5 and 8 hours per night.
- People who usually go to bed between 9pm and midnight.
- People who score 5 or below on the PSQI sleep quality questionnaire.
Who may not be able to join:
- People who have a sleep disorder other than insomnia, such as restless legs syndrome, sleepwalking or other sleep behaviours, a body clock disorder, or moderate-to-severe sleep apnoea (confirmed by a home sleep test).
- People who habitually go to bed before 9pm or regularly wake before 5am.
- People with a history of neurological conditions (conditions affecting the brain or nervous system).
- People with a history of psychiatric (mental health) conditions.
- People who score above 19 on a standard depression questionnaire called the BDI-II.
- People with unstable or serious ongoing medical conditions.
- People who have been diagnosed with prediabetes or diabetes, or whose blood sugar marker (HbA1c) is 5.7 or higher.
- People who are currently using, or have used in the past month, medications for sleep, mood, stimulation, or pain relief on more than an occasional basis.
- People taking certain medications that affect a specific brain signalling system, including beta-blockers, SNRIs, or NDRIs (confirm with trial site if unsure whether a medication applies).
- People currently using hormone replacement therapy.
- People taking medications that affect pupil size or how the eyes respond to light, such as antihistamines, anticholinergics, benzodiazepines, or narcotic pain medicines.
- People with eye conditions that may affect how pupils respond to light, such as significant cataracts, narrow-angle glaucoma, or blindness.
- People with a history of heart conditions, including irregular heartbeat, coronary artery disease, angina, or heart failure.
- People who do shift work or who follow an irregular sleep schedule by choice.
- People with a BMI (a measure of body weight relative to height) above 35.
- People who regularly smoke six or more cigarettes per week, or consume more than 400mg of caffeine per day.
- People currently using weight-loss medications.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniela Grimaldi, MD, PhD, Northwestern University
Phone: 844-707-5337
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
24h plasma norepinephrine; Clonidine suppression test; Wake after sleep onset (WASO); Slow oscillatory activity during sleep; Pittsburg Sleep Quality Index; NIH tool box
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.